Lipoprotein(a) and Stroke Risk in Over 16,000 Hispanic/Latino Adults: Emerging Insights From the HCHS/SOL Study
Stroke AHA/ASA Journal recently shared a post on X:
”Lipoprotein(a) and Stroke Risk: New Evidence From the Hispanic Community Health Study (HCHS/SOL). In this Blogging Stroke post, Qinglan “Priscilla” Ding discusses Stroke article by Chandra & Duran Luciano et al. AHA Journals – Melissa Lamar, Freddie Marquez.”
Read the article here.
A recent analysis from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), featured in Stroke and discussed in a Blogging Stroke commentary by Qinglan “Priscilla” Ding, sheds new light on the role of lipoprotein(a) [Lp(a)] in cerebrovascular health.
The study by Chandra, Duran Luciano, and colleagues identifies elevated Lp(a) as a significant risk marker not only for overt stroke but also for subclinical cerebrovascular injury detectable on MRI.
These associations are particularly meaningful for Hispanic/Latino populations, who have been historically underrepresented in cardiovascular research.
As Lp(a)-lowering therapies like olpasiran and pelacarsen advance in development, the findings underscore the potential of incorporating Lp(a) screening into targeted stroke prevention strategies for high-risk groups.
Discover more on stroke management in Hemostasis Today.
-
Oct 14, 2025, 06:19Kay Sharma: I Feel Incredibly Proud and Honored to Share the Final Agenda for The ISTH Continuing Education Forum
-
Oct 14, 2025, 06:12Murray Adams: Professor Favaloro Presented Talks On The 100-Year History of von Willebrand Disease
-
Oct 14, 2025, 06:10Samuel Nweke on Significance of MPV in a CBC in Diagnosis
-
Oct 14, 2025, 06:09Francois Delvoye: 5 Days to Go Before the Belgian Stroke Council Scientific Workshop!
-
Oct 14, 2025, 06:08David Smadja: Honored to Take Part in This Special Event for World Thrombosis Day at UM6P University
-
Oct 14, 2025, 06:13Amaliris Guerra: Driving True Innovation in Preclinical Drug Development Related to Iron-Metabolism and Inflammation is One of My Passions!
-
Oct 13, 2025, 03:32Wolfgang Miesbach: This Study from Children's Hospital of Philadelphia Provides Crucial Insights Into Elevidys
-
Oct 13, 2025, 02:43Lukas Meyer and Colleagues on Reperfusion-dependent Treatment Effects of Thrombectomy in Large Ischemic Infarcts
-
Oct 12, 2025, 10:14Hatim Lokhandwala: Landmark HI-PRO Trial Redefines VTE Treatment Guidelines
-
Oct 12, 2025, 07:28Roberta Gualtierotti: rFVIIIFc and rFIXFc Ensured Effective Haemostasis and Favourable Safety in Major Orthopaedic Surgery
-
Oct 13, 2025, 02:46Flora Peyvandi: First Proposed Blood Test for Chronic Fatigue Syndrome - What Scientists Think
-
Oct 13, 2025, 02:44Silvio Maresca: Honored to be part of this international research project - ThrombUS+
-
Oct 10, 2025, 12:25Robert Lewis: T Cells Are Wonderful - But They Can't Do Everything
-
Oct 9, 2025, 13:03Peter Graves: When the Bleeding Does Not Stop
-
Oct 8, 2025, 12:44Bobur Kholikov: Thrombosis Diagnostics with YHLO
-
Oct 14, 2025, 06:11Souad Ahmed: It Was Such A Treat to Attend the 2025 AIMS Travelling Orator Session
-
Oct 14, 2025, 06:06Tara Miller: One of My Favorite Parts of My Job Is Partnering With Passionate Teams Like ISTH
-
Oct 14, 2025, 06:05Pierre Grès: Honored to Share With You My Recent Award for Best Oral Presentation And My Experiences at The Congress of SFTH
-
Oct 14, 2025, 01:16Louise Bannon: Thank You to My Dear Friend, Justin Romanello, Who Shared His Blood Clot Survivor Story With ISTH World Thrombosis Day Campaign
-
Oct 13, 2025, 03:44Jorge Monge: It Was An Honor to Take Part in the 3rd EBA Workshop on Rare Blood Provision